Cargando…

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma

In HIV-seronegative patients with advanced Hodgkin lymphoma (HL), Epstein–Barr virus (EBV) viraemia at diagnosis predicts a worse progression-free survival (PFS), independent of the International Prognostic Score. However, its role in HIV-associated HL is uncharacterised. We collected clinico-pathol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ul-Haq, Ikram, Dalla Pria, Alessia, Suardi, Elisa, Pinato, David J., Froeling, Fieke, Forni, John, Randell, Paul, Bower, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849636/ https://www.ncbi.nlm.nih.gov/pubmed/29536181 http://dx.doi.org/10.1007/s12032-018-1099-2

Ejemplares similares

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Epstein-Barr virus and the origin of Hodgkin lymphoma
por: Vockerodt, Martina, et al.
Publicado: (2014)

Epstein Barr Virus-Associated Hodgkin Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2018)

The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma
por: Venturelli, Serena, et al.
Publicado: (2015)

Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Begić, Valerija, et al.
Publicado: (2022)

Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma
por: Sarwari, Nawid M., et al.
Publicado: (2016)

Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

Recent advances in HIV-associated Kaposi sarcoma
por: Dalla Pria, Alessia, et al.
Publicado: (2019)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Hemophagocytic Lymphohistiocytosis in a Patient with Hodgkin Lymphoma, HIV, and Epstein-Barr Virus
por: Javed, Faiza, et al.
Publicado: (2023)

The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy
por: Dalla Pria, Alessia, et al.
Publicado: (2015)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Hemophagocytic Lymphohistiocytosis Induced by Epstein-Barr Virus Infection and Newly Diagnosed Hodgkin Lymphoma
por: Landry, Ian, et al.
Publicado: (2021)

Epstein–Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient
por: Forster, Moriah, et al.
Publicado: (2022)

Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin’s Lymphoma
por: Leonard, Sarah, et al.
Publicado: (2012)

The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein–Barr virus presence and location within the tumor
por: Wu, R, et al.
Publicado: (2016)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon
por: Bikoï, Jacky Njiki, et al.
Publicado: (2022)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

Epstein–Barr virus-associated lymphomas
por: Shannon-Lowe, Claire, et al.
Publicado: (2017)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Santisteban-Espejo, Antonio, et al.
Publicado: (2021)

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
por: Hu, Jianyu, et al.
Publicado: (2022)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Evidence that Amphotericin B Mediates Reactivation of Latent Epstein-Barr Virus in Hodgkin's Lymphoma Allowing Cytotoxicity by Acyclovir
por: Kast, Richard E.
Publicado: (2006)

Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells
por: Pavlovic, Antonia, et al.
Publicado: (2016)

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
por: Kim, Seok-Jin, et al.
Publicado: (2019)

Variable Expression of Notch1 and Pax5 in Classical Hodgkin Lymphoma and Infection with Epstein–Barr in Pediatric Patients
por: Palma-Lara, Icela, et al.
Publicado: (2020)

HLA-DPB1 and Epstein-Barr virus gp42 protein jointly contribute to the development of Hodgkin lymphoma
por: Li, Hongyu, et al.
Publicado: (2020)

Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.
por: Mueller, N.
Publicado: (1987)

Epstein-Barr virus-associated Hodgkin's disease following renal transplantation
por: Choi, Jung-Hye, et al.
Publicado: (2006)

Immunotherapy for Epstein-Barr Virus-Related Lymphomas
por: Kennedy-Nasser, Alana A., et al.
Publicado: (2009)

Epstein barr virus IgG and EBER-1 in Burkitt’s lymphoma children at a referral hospital in western Kenya
por: Ndede, Isaac, et al.
Publicado: (2019)

Loss of P16 Protein Expression and Its Association with Epstein-Barr Virus LMP-1 Expression in Hodgkin's Lymphoma
por: Irshaid, Fawzi, et al.
Publicado: (2013)

Epstein‐Barr Virus‐associated Post‐transplant Non‐Hodgkin's Lymphoma: Establishment and Characterization of a New Cell Line
por: Kawashima, Kunihiro, et al.
Publicado: (1994)

Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
por: Rao, Sieta P, et al.
Publicado: (2007)

Epstein-Barr viral microRNAs target caspase 3
por: Harold, Cecelia, et al.
Publicado: (2016)

Frequency of Epstein-Barr virus DNA sequences in human gliomas: Frequência de sequências de DNA do vírus Epstein-Barr em gliomas humanos
por: Fonseca, Renata Fragelli, et al.
Publicado: (2014)

Discussion of Epidemiologic Studies Assessing the Role of the Epstein-Barr Virus in Hodgkin's Disease
por: Grufferman, Seymour
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_4ecmna7pepkrd2e644010liasg